🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchTRIUMPH program (retatrutide) — my results so far Page 3

TRIUMPH program (retatrutide) — my results so far

BenResearch_OR Fri, Jan 31, 2025 at 9:18 PM 42 replies 1,987 viewsPage 3 of 9
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Feb 5, 2025 at 6:13 AM#11
Dr.NateNeph said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

38 11maya_sedona, stefan_berlin, Dr.EM_Chicago and 35 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Feb 5, 2025 at 1:14 PM#12
matt_MKE said:
The glucagon component looks paradoxical and is not.

Saving this. It is the first explanation that did not require me to already understand it.

39 12JessicaH_TX, KevinCompounds, TirzTom and 36 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Feb 5, 2025 at 8:14 PM#13
Dr.NateNeph said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

Last edited: Feb 6, 2025 at 1:14 AM
40 13rachel_ABQ, traveltech_sara, AttorneyGrant and 37 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Feb 6, 2025 at 3:14 AM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

I would rather be corrected than agreed with, if it comes to it.

41 14Dr.MetabolicMD, RetaRick_CA, JenPlateau and 38 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 6, 2025 at 10:14 AM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out.

Last edited: Feb 6, 2025 at 2:14 PM
42 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 39 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register